Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Condition: Breast Cancer Intervention: Drug: metronomic oral vinorelbine plus anlotinib Sponsor: Yan Xue Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Conditions: Oral Squamous Cell Carcinoma; Oral Mucositis Interventions: Drug: Alfacalcidol Oral Solution; Drug: Placebo Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Efficacy and Safety of Metronomic Oral Vinorelbine Plus Anlotinib in HER2-negative Metastatic Breast Cancer Patients
Condition: Breast Cancer Intervention: Drug: metronomic oral vinorelbine plus anlotinib Sponsor: Yan Xue Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Using Vitamin D to Reduce Oral Mucosal Inflammation in Chemotherapy Patients With Oral Squamous Cell Carcinoma
Conditions: Oral Squamous Cell Carcinoma; Oral Mucositis Interventions: Drug: Alfacalcidol Oral Solution; Drug: Placebo Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 29, 2023 Category: Research Source Type: clinical trials
Neoadjuvant Tislelizumab Plus Chemotherapy for Locally Advanced Oral/Oropharyngeal Cancer (NeoSPOT)
Conditions: Oral Squamous Cell Carcinoma; Oropharyngeal Squamous Cell Carcinoma Interventions: Drug: Tislelizumab; Drug: Albumin-Bound Paclitaxel; Drug: Cisplatin Sponsor: Peking University Hospital of Stomatology Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 24, 2023 Category: Research Source Type: clinical trials